XPH Among Health Care ETFs
End-of-day Nov 17, 2026 · 39 Health care ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.8% | −5.5% | +3.1% | −13.3% | +14.9% | +27.0% | +88.2% | +31.8% | +83.5% | +418.7% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$44 of every $1,000 in XPH is Xeris
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XERSXeris Biopharma | Healthcare | 4.42% | $442.43 | 1.4M | $23.3M |
| 2 | MANEVeradermics | Healthcare | 2.62% | $262.42 | 108K | $13.8M |
| 3 | LLYELI Lilly + | Healthcare | 2.60% | $260.11 | 9,578 | $13.7M |
| 4 | VTRSViatris | Healthcare | 2.57% | $256.75 | 653K | $13.5M |
| 5 | PCRXPacira Biosciences | Healthcare | 2.54% | $254.17 | 367K | $13.4M |
| 6 | AMRXAmneal Pharmaceuticals | Healthcare | 2.51% | $251.39 | 624K | $13.3M |
| 7 | MAZEMAZE Therapeutics | Healthcare | 2.51% | $250.65 | 390K | $13.2M |
| 8 | ZTSZoetis | Healthcare | 2.35% | $235.13 | 147K | $12.4M |
| 9 | RPRXRoyalty Pharma | Healthcare | 2.31% | $231.01 | 178K | $12.2M |
| 10 | PRGOPerrigo | Healthcare | 2.30% | $230.47 | 751K | $12.1M |
| 11 | ELANElanco Animal Health | Healthcare | 2.29% | $229.07 | 457K | $12.1M |
| 12 | ETONETON Pharmaceuticals | Healthcare | 2.22% | $221.79 | 183K | $11.7M |
| 13 | COLLCollegium Pharmaceutical | Healthcare | 2.17% | $217.16 | 450K | $11.4M |
| 14 | JNJJohnson + Johnson | Healthcare | 2.16% | $216.09 | 40K | $11.4M |
| 15 | LGNDLigand Pharmaceuticals | Healthcare | 2.14% | $213.95 | 37K | $11.3M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XERS | Xeris Biopharma | 4.42% |
| 2 | MANE | Veradermics | 2.62% |
| 3 | LLY | ELI Lilly + | 2.60% |
| 4 | VTRS | Viatris | 2.57% |
| 5 | PCRX | Pacira Biosciences | 2.54% |
| 6 | AMRX | Amneal Pharmaceuticals | 2.51% |
| 7 | MAZE | MAZE Therapeutics | 2.51% |
| 8 | ZTS | Zoetis | 2.35% |
| 9 | RPRX | Royalty Pharma | 2.31% |
| 10 | PRGO | Perrigo | 2.30% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.0416 |
| Jun 22, 2026 | Jun 24, 2026 | $0.0590 |
| Mar 23, 2026 | Mar 25, 2026 | $0.0610 |
| Dec 22, 2025 | Dec 24, 2025 | $0.11 |
| Sep 22, 2025 | Sep 24, 2025 | $0.10 |
| Jun 23, 2025 | Jun 25, 2025 | $0.0959 |
| Mar 24, 2025 | Mar 26, 2025 | $0.15 |
| Dec 23, 2024 | Dec 26, 2024 | $0.15 |
| Sep 23, 2024 | Sep 25, 2024 | $0.19 |
| Jun 24, 2024 | Jun 26, 2024 | $0.16 |
| Mar 18, 2024 | Mar 21, 2024 | $0.17 |
| Dec 18, 2023 | Dec 21, 2023 | $0.17 |